Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Eli Lilly says more Phase 3 trial results are expected later this year, including studies involving people with diabetes and cardiovascular disease
Legal Status / FDA GHRP-2 is not FDA-approved for any indication in the United States
Apr 24, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 4,673 views Could taking a pill instead of an injection change how early people begin treatment for type 2 diabetes or obesity
PMC review 2025 Clinical Trial Results: What the Data Actually Shows This is the section that matters most
US$ 28.14
US$ 27.34
US$ 25.21
